These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

666 related articles for article (PubMed ID: 33403970)

  • 61. Quantification of Adverse Drug Reactions Related to Drug Switches in The Netherlands.
    Glerum PJ; Maliepaard M; de Valk V; Scholl JHG; van Hunsel FPAM; van Puijenbroek EP; Burger DM; Neef K
    Clin Transl Sci; 2020 May; 13(3):599-607. PubMed ID: 32052597
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Analysis of spontaneous reporting of suspected adverse drug reactions for non-analgesic over-the-counter drugs from 2008 to 2017.
    Bukic J; Rusic D; Mas P; Karabatic D; Bozic J; Seselja Perisin A; Leskur D; Krnic D; Tomic S; Modun D
    BMC Pharmacol Toxicol; 2019 Oct; 20(1):60. PubMed ID: 31627740
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Adverse drug reactions in a psychiatric department of tertiary care teaching hospital in India: Analysis of spontaneously reported cases.
    Patel TK; Bhabhor PH; Desai N; Shah S; Patel PB; Vatsala E; Panigrahi S
    Asian J Psychiatr; 2015 Oct; 17():42-9. PubMed ID: 26216702
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The quality of spontaneous adverse drug reaction reports from the pharmacovigilance centre in western China.
    Niu R; Xiang Y; Wu T; Zhang Z; Chen Y; Feng B
    Expert Opin Drug Saf; 2019 Jan; 18(1):51-58. PubMed ID: 30574811
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The contribution of Ghanaian patients to the reporting of adverse drug reactions: a quantitative and qualitative study.
    Jacobs TG; Hilda Ampadu H; Hoekman J; Dodoo ANO; Mantel-Teeuwisse AK
    BMC Public Health; 2018 Dec; 18(1):1384. PubMed ID: 30563498
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Online reporting of adverse drug reactions: a study from a French regional pharmacovigilance center.
    Abadie D; Chebane L; Bert M; Durrieu G; Montastruc JL
    Therapie; 2014; 69(5):395-400. PubMed ID: 25269141
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Adverse drug reactions of analgesic medicines: analysis of the Romanian pharmacovigilance database.
    Cazacu I; Stroe R; Dondera R; Mogosan C; Haramburu F; Fourrier-Réglat A; Loghin F
    Fundam Clin Pharmacol; 2018 Jun; 32(3):330-336. PubMed ID: 29314262
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Completeness of Spontaneous Adverse Drug Reaction Reports Sent by General Practitioners to a Regional Pharmacovigilance Centre: A Descriptive Study.
    Durrieu G; Jacquot J; Mège M; Bondon-Guitton E; Rousseau V; Montastruc F; Montastruc JL
    Drug Saf; 2016 Dec; 39(12):1189-1195. PubMed ID: 27688025
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Targeted therapies and adverse drug reactions in oncology: the role of clinical pharmacist in pharmacovigilance.
    Fornasier G; Taborelli M; Francescon S; Polesel J; Aliberti M; De Paoli P; Baldo P
    Int J Clin Pharm; 2018 Aug; 40(4):795-802. PubMed ID: 29785683
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Pharmacovigilance of parenterally administered salvianolate based on analysis of spontaneous reporting system data].
    Lu PF; Xiang YY; Xie YM; Chang YP; Wang ZG
    Zhongguo Zhong Yao Za Zhi; 2013 Sep; 38(18):3003-7. PubMed ID: 24471320
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Healthcare professionals and pharmacovigilance of pediatric adverse drug reactions: a 5-year analysis of Adverse Events Reporting System Database of the Food and Drug Administration.
    Bigi C; Tuccori M; Bocci G
    Minerva Pediatr (Torino); 2022 Jun; 74(3):272-280. PubMed ID: 28211644
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Mapping the safety profile of biologicals: a disproportionality analysis using the WHO adverse drug reaction database, VigiBase.
    Giezen TJ; Mantel-Teeuwisse AK; Meyboom RH; Straus SM; Leufkens HG; Egberts TC
    Drug Saf; 2010 Oct; 33(10):865-78. PubMed ID: 20812771
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Addressing the under-reporting of adverse drug reactions in public health programs controlling HIV/AIDS, Tuberculosis and Malaria: A prospective cohort study.
    Avong YK; Jatau B; Gurumnaan R; Danat N; Okuma J; Usman I; Mordi D; Ukpabi B; Kayode GA; Dutt S; El-Tayeb O; Afolabi B; Ambrose I; Agbaji O; Osakwe A; Ibrahim A; Ogar C; Nosiri H; Avong EB; Adekanmbi V; Uthman O; Abimiku A; Oni YO; Mensah CO; Dakum P; Mberu KE; Ogundahunsi OAT
    PLoS One; 2018; 13(8):e0200810. PubMed ID: 30133453
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Differences between Drug-Induced and Contrast Media-Induced Adverse Reactions Based on Spontaneously Reported Adverse Drug Reactions.
    Ryu J; Lee H; Suh J; Yang M; Kang W; Kim E
    PLoS One; 2015; 10(11):e0142418. PubMed ID: 26544039
    [TBL] [Abstract][Full Text] [Related]  

  • 75. A comprehensive intervention for adverse drug reactions identification and reporting in a Pediatric Emergency Department.
    Morales Ríos O; Jasso Gutiérrez L; Talavera JO; Téllez-Rojo MM; Olivar López V; Garduño Espinosa J; Muñoz Hernández O
    Int J Clin Pharm; 2016 Feb; 38(1):80-7. PubMed ID: 26499501
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Profile of adverse drug reaction reports in South Africa: An analysis of VigiBase® for the year 2017.
    Steyn H
    S Afr Med J; 2023 Jun; 113(6):26-33. PubMed ID: 37278262
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Adverse drug reactions' reporting in a Mexican hospital.
    Valdez-Ramírez LA; Serrano-Medina A; Cornejo-Bravo JM
    Int J Pharm Pract; 2020 Dec; 28(6):660-662. PubMed ID: 32476179
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Adverse drug reaction reports for cardiometabolic drugs from sub-Saharan Africa: a study in VigiBase.
    Berhe DF; Juhlin K; Star K; Beyene KG; Dheda M; Haaijer-Ruskamp FM; Taxis K; Mol PG
    Trop Med Int Health; 2015 Jun; 20(6):797-806. PubMed ID: 25704305
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Neonatal adverse drug reactions: an analysis of reports to the French pharmacovigilance database.
    Kaguelidou F; Beau-Salinas F; Jonville-Bera AP; Jacqz-Aigrain E
    Br J Clin Pharmacol; 2016 Oct; 82(4):1058-68. PubMed ID: 27276109
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Assessing the feasibility of using an adverse drug reaction preventability scale in clinical practice: a study in a French emergency department.
    Olivier P; Boulbés O; Tubery M; Lauque D; Montastruc JL; Lapeyre-Mestre M
    Drug Saf; 2002; 25(14):1035-44. PubMed ID: 12408734
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.